Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Reports Q4 and Full Year 2010 Diluted EPS of $0.76 and $3.12, Respectively. Q4 and Full Year 2010 Adjusted Diluted EPS Were $0.83 and $3.31, Respectively. Q4 Sales Set New Quarterly High. 2011 Diluted EPS Expected to be
Date:2/9/2011

ely grew 27% and 23% on a reported and organic basis, respectively, for the fourth quarter of 2010.
  • SAFC's booked orders for future delivery at December 31, 2010 improved over the September 30, 2010 level and were 10% above the December 31, 2009 level.

  • 2011 OUTLOOK:

  • Organic sales growth is expected to be in the mid-single digit range for 2011.
  • Programs to enhance and highlight our product capabilities for our research business in analytical, biology chemistry and materials science, continued emphasis on growth opportunities in fine chemicals, in international markets and in e-commerce are all expected to enable us to achieve 2011 sales growth at above market rates.
  • Market conditions are not expected to change much from 2010.
  • At current exchange rates, currency is not expected to have a significant impact on full year reported sales growth.  
  • The recently completed acquisitions of Cerilliant and Research Technology Corporation are expected to contribute a modest sales benefit.
  • Our forecast for diluted adjusted earnings per share for 2011 is $3.45 to $3.60, up from an adjusted diluted EPS of $3.31 for 2010.  
  • This increase reflects expected benefits from higher sales levels and ongoing cost management activities.
  • Included in this outlook are expenses for strategic initiatives that are expected to drive longer term organic sales growth to a level of 7% to 8%.
  • The effective tax rate in 2011 is expected to be approximately 30%, including a benefit from the U.S. R & D tax credit comparable to that realized in 2010.
  • Recent acquisitions are expected to be neutral to mildly accretive to our diluted earnings per share in 2011.  
  • This EPS outlook excludes the impact of restructuring and other extraordinary special charges.
  • Management expects free cash flow for 2011 to be in excess of $375 million.
  • Net cash provided by operati
    '/>"/>

  • SOURCE Sigma-Aldrich
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. Sigma-Aldrich to Present at the JP Morgan 29th Annual Healthcare Conference on Monday, January 10, 2011.
    2. Sigma-Aldrich Acquires Cerilliant Corporation to Strengthen its Analytical Chemistry Portfolio
    3. Sigma-Aldrich Corporation Announces Death of Chairman and CEO; Election of New CEO and Chairman; Conference Call Scheduled for 10:00a.m. (Central Time) on November 15, 2010
    4. Sigma-Aldrich Announces Pricing of Senior Notes
    5. Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 -
    6. Sigma-Aldrich to Present at the UBS Global Life Sciences Healthcare Conference on Tuesday, September 21, 2010
    7. Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO)
    8. Sigma-Aldrich Corporation to Present at the Bairds 2010 Growth Stock Conference on Thursday, May 20, 2010
    9. Sigma-Aldrich (Nasdaq: SIAL) Announces Executive Management Changes: Retirement of David Julien and Promotion of Joseph Porwoll
    10. Sigma-Aldrich to Present at the Bank of America Merrill Lynch 2010 Health Care Conference on Wednesday, May 12, 2010
    11. Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/4/2015)... , ... August 05, 2015 , ... ... the “Product Handbook – the complete product line.” The handbook provides a ... “This new product handbook consolidates our complete standard product offering into an easy-to-navigate ...
    (Date:8/4/2015)... Inc. (NYSE: BIOA ), a leader in renewable ... ending June 30, 2015. Highlights included: , The Sarnia ... The final cost of the Sarnia plant is projected ... high end of the estimate communicated at the onset ... The company announced commercial collaborations in two targeted industry ...
    (Date:8/4/2015)... ... August 04, 2015 , ... Graphite Metallizing Corporation, ... equipment, announces the appointment of Dennis Rawle as European Director of Sales. Rawle ... recently, he was General Manager and Technical Sales Manager for pump products at ...
    (Date:8/4/2015)... PORTLAND, Oregon , August 4, 2015 /PRNewswire/ ... published by Allied Market Research, titled, "World Cardiac ... global cardiac biomarker market would generate the revenue ... of 18.9% from 2015 to 2020. Cardiac Troponins ... throughout the forecast period due to high sensitivity ...
    Breaking Biology Technology:Spirax Sarco releases Product Handbook 2BioAmber Reports Second Quarter 2015 Financial Results 2BioAmber Reports Second Quarter 2015 Financial Results 3BioAmber Reports Second Quarter 2015 Financial Results 4BioAmber Reports Second Quarter 2015 Financial Results 5BioAmber Reports Second Quarter 2015 Financial Results 6BioAmber Reports Second Quarter 2015 Financial Results 7BioAmber Reports Second Quarter 2015 Financial Results 8BioAmber Reports Second Quarter 2015 Financial Results 9BioAmber Reports Second Quarter 2015 Financial Results 10BioAmber Reports Second Quarter 2015 Financial Results 11BioAmber Reports Second Quarter 2015 Financial Results 12Dennis Rawle Joins Graphite Metallizing Corporation 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 4Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 5
    ... SAN DIEGO, March 6 Cadence Pharmaceuticals,Inc. (Nasdaq: ... in-licensing,developing and commercializing proprietary product candidates principally,for use ... will release its,fourth quarter and full year ended ... market on Wednesday, March 12, 2008., Cadence ...
    ... PICK: Pinpoint accuracy: DNA vaccines that home in on ... pursued to develop new vaccines against infectious diseases is ... a DNA vaccine, the body converts the information in ... immune response. However, current DNA vaccines induce relatively weak ...
    ... Elsevier, the world-leading publisher of scientific, technical and ... Materials 2009: The First International Conference on Multifunctional, ... Tours, France, 15-19 March 2009. , Research ... growth in published papers in recent years with ...
    Cached Biology Technology:Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008 2JCI online early table of contents: March 6, 2008 2JCI online early table of contents: March 6, 2008 3JCI online early table of contents: March 6, 2008 4Hybrid materials: Exciting interdisciplinary field offering future solutions for industry 2
    (Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
    (Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
    (Date:7/8/2015)... N.J. and NEW YORK , July 8, ... Guidepoint today announced BD & Guidepoint Mentor, ... with free access to Guidepoint,s expert network services. ... are developing cutting-edge technologies to improve healthcare delivery and ... research manager, each start-up entrepreneur will be able to ...
    Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
    ... boosts in the microbial production of clean, green and ... of a new technique in synthetic biology by researchers ... Institute (JBEI). This new technique dubbed a ... in microbes during the production of fatty acid-based fuels ...
    ... York, N.Y. (March 26, 2012) Autism Speaks, the ... the award of new research grants totaling $1.1 million ... I are extraordinarily proud of Autism Speaks, continued funding ... open new avenues to understanding autism," said Autism Speaks ...
    ... and narwhals live solely in the cold waters of the ... not have always been the case. They recently described a ... belugas and narwhals that lived some 3-4 million years ago ... when its modern-day relatives evolved to live only in northern ...
    Cached Biology News:New synthetic biology technique boosts microbial production of diesel fuel 2New synthetic biology technique boosts microbial production of diesel fuel 3New synthetic biology technique boosts microbial production of diesel fuel 4Autism Speaks awards $1.1 million to fund high priority studies 2Autism Speaks awards $1.1 million to fund high priority studies 3Ancient whale species sheds new light on its modern relatives 2
    Anti-Human Factor XIII HRPO (Polyclonal) (sheep IgG)...
    ... Mouse monoclonal [F30 P7 D7 ... for all tested applications). ... conjugated to Ovalbumin, corresponding to amino ... Entrez Gene ID: ...
    E2F-5...
    LAB/Probe Mouse-Rabbit DAB Kit...
    Biology Products: